Form 4 filed by KIDRON NADAV
KIDRON NADAV filed this Form 4 on ORAMED PHARMACEUTICALS INC. with 8 transaction rows and 1 holding row, accepted by EDGAR 2026-09-25 20:31:26 UTC.
- Accession
- 0001213900-26-103540
- Filer
- CIK 1351779
- Filed
- 2026-09-25
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: ORAMED PHARMACEUTICALS INC. (CIK 1176309)
- KIDRON NADAV director, officer (President and CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-24 | A granted | +349,497 | 3,771,740 | D | |
| Common Stock | 2026-09-24 | A granted | +368,765 | 4,140,505 | D | |
| Common Stock holding | 126,000 | I By wholly-owned corporation | ||||
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -196,500 | 0 | D | |
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -190,000 | 0 | D | |
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -49,000 | 0 | D | |
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -97,000 | 0 | D | |
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -150,000 | 0 | D | |
| Stock option (right to buy) derivative | 2026-09-24 | D returned to the issuer | -107,000 | 0 | D |